Compare SNEX & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNEX | CRL |
|---|---|---|
| Founded | 1924 | 1947 |
| Country | United States | United States |
| Employees | 5400 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 10.8B |
| IPO Year | 1996 | 1999 |
| Metric | SNEX | CRL |
|---|---|---|
| Price | $77.30 | $261.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | $81.33 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 883.7K | 786.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.74 | N/A |
| Revenue | ★ $132,378,200,000.00 | $1,857,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.17 | $3.04 |
| P/E Ratio | $20.10 | ★ N/A |
| Revenue Growth | ★ 32.53 | 10.48 |
| 52 Week Low | $68.00 | $144.26 |
| 52 Week High | $141.99 | $242.73 |
| Indicator | SNEX | CRL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 76.17 |
| Support Level | N/A | $153.47 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 7.39 |
| MACD | 0.00 | 1.28 |
| Stochastic Oscillator | 0.00 | 100.00 |
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.